This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.
The total number entries retrieved from this search are 378Biomarker ID | Biomarker | Biomolecule | Subject | Regulation | Biomarker's type | Experiment | Level of significance | Source | PMID |
---|---|---|---|---|---|---|---|---|---|
2158 | hnRNP K | Protein | Human | Upregulated in HCC | Diagnostic | Early HCC vs Late HCC | p < 0.01 | Serum | 22760167 |
2159 | hnRNP K, AFP | Protein | Human | Upregulated in HCC | Diagnostic | Early HCC vs Late HCC | p < 0.01 | Serum | 22760167 |
2164 | Apo-A4 | Protein | Human | Downregulated in HCC patients | Diagnostic | HCC v/s other liver disease (cirrhosis/ALD) | p < 0.01 | Plasma | 21160983 |
2165 | APO-A1 | Protein | Human | Upregulated in HCC patients | Diagnostic | HCC v/s other liver disease (cirrhosis/ALD) | p < 0.01 | Plasma | 21160983 |
2166 | APO-A1, Apo-A4 | Protein | Human | APO-A4 Upregulated and APO-A1 downregulated in HCC patients | Diagnostic | HCC v/s other liver disease (cirrhosis/ALD) | p < 0.01 | Plasma | 21160983 |
2178 | miR-122 | miRNA | Human | variable expression between different hepatoma cell lines: PLC/PRF/5, Huh-1, and Hep40 exhibited very high levels of miR-122, whereas others, such as Hep3B and HepG2, expressed little or did not express miR-122 at all (e.g. SNU387, and SNU398) ; in HCC patients miR-122 was specifically repressed in | Diagnostic and Prognostic | Normal vs HCC; associated with survival, tumor size and differentiation status | p < 0.001 | Tissue and Cells | 19617899 |
2179 | lamin B1 | Protein | Human | Upregulated in liver cancer patients | Diagnostic and Prognostic | Normal vs HCC; significantly associated with the increased number of tumor nodules , the size of tumors, and tumor stage | p < 0.01 | Plasma | 19522540 |
2180 | circCDK13 | circRNAs | Human | Suppressed expression in liver cancer | Diagnostic | Normal cell line vs cancer cell line | p < 0.05 | Tissue | 29658568 |
2181 | miR-101-3p, miR-106b-3p, miR-1246 | miRNA | Human | Upregulated in HCC | Diagnostic | HCC v/s Cirrhosis | p < 0.001 | Plasma | 29632649 |
2182 | miR-101-3p | miRNA | Human | Upregulated in HCC | Diagnostic | HCC v/s Cirrhosis | p < 0.001 | Plasma | 29632649 |
2183 | miR-1246 | miRNA | Human | Upregulated in HCC | Diagnostic | HCC v/s Cirrhosis | p < 0.001 | Plasma | 29632649 |
2184 | miR-106b-3p | miRNA | Human | Upregulated in HCC | Diagnostic | HCC v/s Cirrhosis | p < 0.001 | Plasma | 29632649 |
2185 | miR-101-3p, miR-106b-3p | miRNA | Human | Upregulated in HCC | Diagnostic | HCC v/s Cirrhosis | p < 0.001 | Plasma | 29632649 |
2186 | miR-101-3p, miR-1246 | miRNA | Human | Upregulated in HCC | Diagnostic | HCC v/s Cirrhosis | p < 0.001 | Plasma | 29632649 |
2187 | miR-106b-3p, miR-1246 | miRNA | Human | Upregulated in HCC | Diagnostic | HCC v/s Cirrhosis | p < 0.001 | Plasma | 29632649 |
2188 | miR-101-3p | miRNA | Human | Upregulated in HCC | Diagnostic | HCC v/s Control | p < 0.001 | Plasma | 29632649 |
2189 | miR-101-3p, miR-106b-3p, miR-1246 | miRNA | Human | Upregulated in HCC | Diagnostic | HCC v/s Control | p < 0.001 | Plasma | 29632649 |
2190 | miR-1246 | miRNA | Human | Upregulated in HCC | Diagnostic | HCC v/s Control | p < 0.001 | Plasma | 29632649 |
2191 | miR-106b-3p | miRNA | Human | Upregulated in HCC | Diagnostic | HCC v/s Control | p < 0.001 | Plasma | 29632649 |
2192 | miR-101-3p, miR-106b-3p | miRNA | Human | Upregulated in HCC | Diagnostic | HCC v/s Control | p < 0.001 | Plasma | 29632649 |
2193 | miR-101-3p, miR-1246 | miRNA | Human | Upregulated in HCC | Diagnostic | HCC v/s Control | p < 0.001 | Plasma | 29632649 |
2194 | miR-106b-3p, miR-1246 | miRNA | Human | Upregulated in HCC | Diagnostic | HCC v/s Control | p < 0.001 | Plasma | 29632649 |
2195 | miR-101-3p | miRNA | Human | Upregulated in HCC | Diagnostic | HCC v/s Cirrhosis | p < 0.001 | Serum | 29632649 |
2196 | miR-106b-3p | miRNA | Human | Upregulated in HCC | Diagnostic | HCC v/s Cirrhosis | p < 0.001 | Serum | 29632649 |
2197 | miR-101-3p, miR-106b-3p | miRNA | Human | Upregulated in HCC | Diagnostic | HCC v/s Cirrhosis | p < 0.001 | Serum | 29632649 |
2198 | miR-26a | miRNA | Human cell line | Downregulated in HepG2 cells | Potential Diagnostic * | Normal cell line vs Liver cancer cell line | p < 0.05 | Cells | 29430178 |
2200 | AFP, (with cut off 0.9 of AFP in serum ) | Protein | Human | NA | Diagnostic | HCC v/s Non-HCC | NA | Serum and Urine | 29152526 |
2201 | BMK, (with cut off 0.40 BMK in Urine) | Protein | Human | NA | Diagnostic | HCC v/s Non-HCC | NA | Serum and Urine | 29152526 |
2202 | AFP, BMK, (with cut off 1.25 of AFP in serum and 0.25 BMK in urine) | Protein | Human | NA | Diagnostic | HCC v/s Non-HCC | NA | Serum and Urine | 29152526 |
2203 | AFP, BMK, (with cut off 1.20 of AFP in serum and 0.27 BMK in urine) | Protein | Human | NA | Diagnostic | HCC v/s Non-HCC | NA | Serum and Urine | 29152526 |
2204 | AFP, BMK, (with cut off 0.90 of AFP in serum and 0.40 BMK in urine) | Protein | Human | NA | Diagnostic | HCC v/s Non-HCC | NA | Serum and Urine | 29152526 |
2205 | AFP, BMK, (with cut off 1.65 of AFP in serum and 0.40 BMK n urine) | Protein | Human | NA | Diagnostic | HCC v/s Non-HCC | NA | Serum and Urine | 29152526 |
2206 | AFP, BMK, (with cut off 0.9 of AFP in serum and 0.75 BMK in urine) | Protein | Human | NA | Diagnostic | HCC v/s Non-HCC | NA | Serum and Urine | 29152526 |
2209 | ITGA2 | Protein | Human | Upregulated in HCC | Diagnostic | HBV-associated HCC v/s healthy/non-tumor/cirrhosis | p < 0.0001 | Tissue | 28947976 |
2210 | BMP4 | Protein | Human | Upregulated in HCC | Diagnostic | HBV-associated HCC v/s healthy/non-tumor/cirrhosis | p < 0.0001 | Tissue | 28947976 |
2211 | PLCB1 | Protein | Human | Upregulated in HCC | Diagnostic | HBV-associated HCC v/s healthy/non-tumor/cirrhosis | p < 0.0001 | Tissue | 28947976 |
2212 | KDM6B | Protein | Human | Downregulated in HCC | Diagnostic | HBV-associated HCC v/s healthy/non-tumor/cirrhosis | p < 0.0001 | Tissue | 28947976 |
2213 | MYC | Protein | Human | Downregulated in HCC | Diagnostic | HBV-associated HCC v/s healthy/non-tumor/cirrhosis | p < 0.0001 | Tissue | 28947976 |
2214 | ITGA2 | Protein | Human | Upregulated in HCC | Diagnostic | HCV-associated HCC v/s healthy/non-tumor/cirrhosis | p < 0.01 | Tissue | 28947976 |
2215 | BMP4 | Protein | Human | Upregulated in HCC | Diagnostic | HCV-associated HCC v/s healthy/non-tumor/cirrhosis | p < 0.01 | Tissue | 28947976 |
2216 | PLCB1 | Protein | Human | Upregulated in HCC | Diagnostic | HCV-associated HCC v/s healthy/non-tumor/cirrhosis | p < 0.01 | Tissue | 28947976 |
2217 | KDM6B | Protein | Human | Downregulated in HCC | Diagnostic | HCV-associated HCC v/s healthy/non-tumor/cirrhosis | p < 0.001 | Tissue | 28947976 |
2218 | MYC | Protein | Human | Downregulated in HCC | Diagnostic | HCV-associated HCC v/s healthy/non-tumor/cirrhosis | p < 0.0001 | Tissue | 28947976 |
2220 | AFP, DCP | Protein | Human | AFP upregulated in HCC | Diagnostic | Normal vs HCC, Cirrhosis | p < 0.001 | Serum | 19852963 |
2221 | DCP, (> =40 mAU/mL) | Protein | Human | DCP upregulated in HCC | Diagnostic | Normal vs HCC, Cirrhosis | p < 0.001 | Serum | 19852963 |
2222 | DCP, (> =150 mAU/mL) | Protein | Human | DCP upregulated in HCC | Diagnostic | Normal vs HCC, Cirrhosis | p < 0.001 | Serum | 19852963 |
2223 | AFP, (> =20 ng/mL) | Protein | Human | AFP and DCP upregulated in HCC | Diagnostic | Normal vs HCC, Cirrhosis | p < 0.001 | Serum | 19852963 |
2224 | AFP, (> =200 ng/mL) | Protein | Human | AFP and DCP upregulated in HCC | Diagnostic | Normal vs HCC, Cirrhosis | p < 0.001 | Serum | 19852963 |
2225 | AFP, DCP, ( DCP with a cut-off value of 86 mAU/mL and AFP with a cut-off value of 21 ng/mL) | Protein | Human | AFP and DCP upregulated in HCC | Diagnostic | HCC v/s Normal | p < 0.001 | Serum | 25382443 |
2226 | AFP, (cut-off value of 21 ng/mL) | Protein | Human | AFP upregulated in HCC | Diagnostic | HCC v/s Normal | p < 0.001 | Serum | 25382443 |